Clinical Trial Update: LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial (LINNOVATE) is evaluating a triple combination of lurbinectedin, ipilimumab, and nivolumab for advanced soft tissue sarcoma; recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Lurbinectedin (lurbinectedin)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: ERLINDA M GORDON | Conditions: Advanced Soft-tissue Sarcoma | Phase 1, Phase 2 | Status: RECRUITING